Company: MLSS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001437749-25-017171
Chunk: 11

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 11
---
 the NJEDA program, the Company must retain a physical presence in the state of New Jersey for a period of5years after the sale of the of the NOLs. If the Company does notretain a physical presence during the5years after the sale of the NOLs, the Company can be liable to pay the state of New Jersey up to $2.2million of the surrendered NOLs.

NOTE9 - SEGMENT AND GEOGRAPHIC DATA

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (the “ CODM”). The Company conducts its business through tworeportable segments: Dental and Medical. These segments offer different products and services to different customer base. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and Operating income (loss).

The Company provides general corporate services to its segments; however, these services are notconsidered when making operating decisions and assessing segment performance. These services are reported under “ Corporate Services” below and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance.

The following tables present information about our reportable and operating segments for the threemonths endedMarch 31, 2025, and2024:

                                                      Dental                                                   
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                        2025                                                   
  Product sales, net                              $2,181,170         51,250                -        2,232,420  
  Cost of products sold                              584,896             89                -          584,985  
  Gross Margin                                     1,596,274         51,161                -        1,647,435  
  Salaries & employee benefits                       441,497        206,115          117,108          764,720  
  Stock-based compensation expense                         -              -          330,788          330,788  
  Royalty expense                                    109,928          2,563                -          112,491  
  Marketing                                           83,629         24,321            4,261          112,211  
  Rent & occupancy costs                              12,521          7,